文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

与类风湿关节炎相关的间质性肺疾病患者死亡的相关因素:系统评价和荟萃分析。

Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.

机构信息

Department of Respiratory and Critical Care Medicine, Yantai Yuhuangding Hospital, Affiliated with the Medical College of Qingdao, 20 Yuhuangding East Road, Yantai, 264200, Shandong, China.

Department of Gastroenterology, Yantai Yuhuangding Hospital, Affiliated with the Medical College of Qingdao, 20 Yuhuangding East Road, Yantai, 264200, Shandong, China.

出版信息

Respir Res. 2021 Oct 11;22(1):264. doi: 10.1186/s12931-021-01856-z.


DOI:10.1186/s12931-021-01856-z
PMID:34635095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8504109/
Abstract

BACKGROUND: Interstitial lung disease (ILD) is a common and potentially life-threatening complication for rheumatoid arthritis (RA) patients. However, there is a lack of clear prognostic factors in rheumatoid arthritis-associated interstitial lung disease (RA-ILD) patients. The purpose of this study was to complete a systematic review and meta-analysis of the factors associated with mortality in RA-ILD patients. METHODS: Medline, EMBASE and the Cochrane Library were searched up to September 1, 2020. The Newcastle-Ottawa Scale (NOS) was applied to assess the methodological quality of the eligible studies. Study characteristics and magnitude of effect sizes were extracted. Then, pooled hazard ratios (HRs) with the corresponding 95% confidence intervals (CIs) and pooled risk ratios (RRs) with 95% CIs were calculated to assess the factors associated with mortality in RA-ILD. RESULTS: Twenty-three of 3463 articles were eligible, and ten factors associated with mortality for RA-ILD were evaluated in the meta-analysis. Older age (HRs = 1.04, 95% CI 1.03-1.05), male sex (HRs = 1.44, 95% CI 1.21-1.73), having a smoking history (HRs = 1.42, 95% CI 1.03-1.96), lower diffusing capacity of the lung for carbon monoxide (DLCO)% predicted (HRs = 0.98, 95% CI 0.97-1.00), forced vital capacity (FVC)% predicted (HRs = 0.99, 95% CI 0.98-1.00), composite physiological index (CPI) (HRs = 1.04, 95% CI 1.02-1.06), usual interstitial pneumonia (UIP) pattern on HRCT (HRs = 1.88, 95% CI 1.14-3.10 and RRs = 1.90, 95% CI 1.50-2.39), emphysema presence (HRs = 2.31, 95% CI 1.58-3.39), and acute exacerbation of ILD (HRs = 2.70, 95% CI 1.67-4.36) were associated with increased mortality in RA-ILD, whereas rheumatoid factor (RF) positive status was not associated. CONCLUSIONS: Through this systematic review and meta-analysis, we found that older age, male sex, smoking history, higher CPI, lower DLCO% predicted, lower FVC% predicted, UIP pattern on HRCT, emphysema presence and acute exacerbation of ILD were associated with an increased risk of mortality in RA-ILD.

摘要

背景:间质性肺疾病(ILD)是类风湿关节炎(RA)患者常见且潜在危及生命的并发症。然而,RA 相关间质性肺疾病(RA-ILD)患者缺乏明确的预后因素。本研究旨在对 RA-ILD 患者死亡相关因素进行系统回顾和荟萃分析。

方法:检索 Medline、EMBASE 和 Cochrane 图书馆,截至 2020 年 9 月 1 日。应用纽卡斯尔-渥太华量表(NOS)评估合格研究的方法学质量。提取研究特征和效应大小。然后,计算合并风险比(HRs)及其相应的 95%置信区间(CIs)和合并风险比(RRs)及其 95%置信区间(CIs),以评估 RA-ILD 患者死亡的相关因素。

结果:3463 篇文章中有 23 篇符合条件,对荟萃分析中与 RA-ILD 死亡率相关的 10 个因素进行了评估。年龄较大(HRs=1.04,95%CI 1.03-1.05)、男性(HRs=1.44,95%CI 1.21-1.73)、吸烟史(HRs=1.42,95%CI 1.03-1.96)、一氧化碳弥散量(DLCO)%预测值较低(HRs=0.98,95%CI 0.97-1.00)、用力肺活量(FVC)%预测值较低(HRs=0.99,95%CI 0.98-1.00)、综合生理指数(CPI)(HRs=1.04,95%CI 1.02-1.06)、高分辨率计算机断层扫描(HRCT)上常见间质性肺炎(UIP)模式(HRs=1.88,95%CI 1.14-3.10 和 RRs=1.90,95%CI 1.50-2.39)、肺气肿存在(HRs=2.31,95%CI 1.58-3.39)和 ILD 急性加重(HRs=2.70,95%CI 1.67-4.36)与 RA-ILD 死亡率增加相关,而类风湿因子(RF)阳性状态与死亡率增加无关。

结论:通过本系统评价和荟萃分析,我们发现年龄较大、男性、吸烟史、较高的 CPI、较低的 DLCO%预测值、较低的 FVC%预测值、HRCT 上的 UIP 模式、肺气肿存在和 ILD 急性加重与 RA-ILD 患者的死亡风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/8504109/adb22a8a73a0/12931_2021_1856_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/8504109/070f61aebd20/12931_2021_1856_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/8504109/f92a152d1351/12931_2021_1856_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/8504109/adb22a8a73a0/12931_2021_1856_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/8504109/070f61aebd20/12931_2021_1856_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/8504109/f92a152d1351/12931_2021_1856_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a896/8504109/adb22a8a73a0/12931_2021_1856_Fig3_HTML.jpg

相似文献

[1]
Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.

Respir Res. 2021-10-11

[2]
Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.

BMC Pulm Med. 2023-7-11

[3]
Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.

PLoS One. 2023

[4]
The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.

Ann Med. 2024-12

[5]
Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.

Semin Arthritis Rheum. 2019-5-15

[6]
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.

Semin Arthritis Rheum. 2022-8

[7]
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.

Respir Med. 2017-6

[8]
Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?

BMC Pulm Med. 2017-1-13

[9]
Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.

Lung. 2019-10-3

[10]
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.

Kaohsiung J Med Sci. 2019-3-26

引用本文的文献

[1]
Prevalence and clinical significance of anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis-associated interstitial lung disease.

BMC Pulm Med. 2025-4-14

[2]
Impact of csDMARDs vs. b/tsDMARDs on the Prognosis of Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Retrospective Study.

Diagnostics (Basel). 2025-3-21

[3]
A comparative study of different types of connective tissue-associated interstitial lung disease.

BMC Med Imaging. 2025-4-7

[4]
Mortality and Predictive Factors for Death Following the Diagnosis of Interstitial Lung Disease in Patients with Rheumatoid Arthritis: A Retrospective, Long-Term Follow-Up Study.

J Clin Med. 2025-2-19

[5]
Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis: 2024 update.

Rheumatol Immunol Res. 2025-1-9

[6]
Risk factors of mortality in patients with rheumatoid arthritis-associated interstitial lung disease: a single-centre prospective cohort study.

Arthritis Res Ther. 2024-7-19

[7]
Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.

Clin Rheumatol. 2024-8

[8]
Rate of severe and fatal infections in a cohort of patients with interstitial lung disease associated with rheumatoid arthritis: a multicenter prospective study.

Front Immunol. 2024

[9]
The interplay between rheumatic diseases and pulmonary health.

Rheumatol Int. 2024-7

[10]
Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study.

PLoS One. 2024

本文引用的文献

[1]
Risk prediction model in rheumatoid arthritis-associated interstitial lung disease.

Respirology. 2020-12

[2]
Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease.

PLoS One. 2020-3-12

[3]
The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.

Med Sci Monit. 2020-3-6

[4]
Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria.

J Thorac Dis. 2019-12

[5]
Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease.

BMC Pulm Med. 2020-1-30

[6]
A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.

Clin Rheumatol. 2020-5

[7]
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.

Cochrane Database Syst Rev. 2019-10-3

[8]
Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality.

Respiration. 2019-10-9

[9]
Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population.

Clin Rheumatol. 2018-12-7

[10]
Predicting outcomes in rheumatoid arthritis related interstitial lung disease.

Eur Respir J. 2019-1-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索